Company news
Genflow Biosciences Plc (LSE:GENF) news
Genflow Biosciences Plc news releases on 6ix. Latest, Aug 18, 2025: Company Update on Dog Trials
Press releases — page 2
Company Update on Dog Trials
August 18, 2025
Genflow Biosciences PLC Announces Clinical Readiness Acceleration
July 24, 2025
Clinical Readiness Acceleration
July 24, 2025
Genflow Confirms Progression of Grant
July 17, 2025
Genflow Biosciences PLC Announces Corporate Update
June 17, 2025
Corporate Update
June 17, 2025
Result of AGM
June 12, 2025
Genflow Signs Master Services Agreement
May 28, 2025
Genflow Biosciences and CER Sign Master Service Agreement to Strengthen Long-Term R&D Collaboration
May 28, 2025
Genflow Biosciences PLC Announces AGM Notice
May 22, 2025
AGM Notice
May 22, 2025
Key SIRT6 Patent Application
May 15, 2025
Genflow Biosciences PLC Announces Key SIRT6 Patent Application
May 15, 2025
Share Subscription, Director's Dealing and Update
May 9, 2025
Genflow Biosciences PLC Announces Share Subscription, Director's Dealing and Update
May 9, 2025
Genflow Biosciences PLC Announces Final Results
April 30, 2025
Final Results
April 30, 2025
Launch of AI-Powered Partnership
April 14, 2025
Genflow Biosciences PLC Announces Launch of AI-Powered Partnership
April 14, 2025
Genflow Launches New Development Program
April 10, 2025
Genflow Biosciences PLC Launches New Development Program
April 10, 2025
Holding in Company
March 28, 2025
Genflow Biosciences PLC Announces Director Dealings
March 28, 2025
Director Dealings
March 28, 2025
Institutional Investment
March 26, 2025
Genflow Biosciences PLC Announces Institutional Investment
March 26, 2025
Genflow Biosciences PLC Announces Advancements in SIRT6 Variant Patent Application
February 20, 2025
Advancements in SIRT6 Variant Patent Application
February 20, 2025
2024 Highlights
January 6, 2025
Genflow Secures Non-Dilutive Financial Support
October 22, 2024
Strengthening of Pre-Clinical Efforts
June 27, 2024
Receipt of Grant Funding
June 12, 2024
Notice of AGM
June 3, 2024
Restoration - GENFLOW BIOSCIENCES PLC
May 8, 2024
Restoration of Listing
May 8, 2024
Full Text of Accounts
May 7, 2024
Temporary Suspension
May 1, 2024
Suspension - GENFLOW BIOSCIENCES PLC
May 1, 2024
NOTIFICATION OF MAJOR HOLDINGS
April 10, 2024
Genflow Biosciences attracts new institutional investors with £715,000 fundraise
April 8, 2024
Successful Placing and Subscription
April 4, 2024
Publication of a Key European Patent
March 21, 2024
Highlights and Key Priorities
February 1, 2024
Two Non-Dilutive Research Grant Awards
January 18, 2024
Appointment of Joint Broker
November 8, 2023
Company Update
September 20, 2023
Admittance to trading on the OTCQB Venture Market
June 13, 2023
Results of Annual General Meeting
June 8, 2023
Notice of Annual General Meeting
May 16, 2023
Appointment and Internal Restructure
May 11, 2023